EFFECT OF DIFFERENT TECHNIQUES OF ABLATION OF ATRIAL FIBRILLATION ON THE HEART AUTONOMOUS TONE

To compare heart rate variability in patients with paroxysmal and persistent atrial fibrillation following the catheter ablation of atrial fibrillation using different techniques, 52 patients were assessed in January 2015 through January 2016.

atrial fibrillation, radiofrequency catheter ablation, cryoballoon ablation, left atrium, pulmonary veins, autonomous nervous system, heart rate variability

1. Additional benefit of cryoballoon-based atrial fibrillation ablation beyond pulmonary vein isolation: modification of ganglionated plexi / H. Yorgun [et al.] // Europace. - 2014. - Vol. 16(5). - P. 645-651.

2. Atrio-oesophageal fistula: an emergent complication of radiofrequency ablation / W. Hazell [et al.] // Emerg Med Australas. - 2009. - Vol. 21(4). - P. 329-332.

3. Autonomic denervation added to pulmonary vein isolation for paroxysmal atrial fibrillation: a randomized clinical trial / D.G. Katritsis [et al.] // J Am Coll Cardiol. - 2013. -Vol. 62(24). - P. 2318-2325.

4. Catheter ablation of cardiac autonomic nerves for prevention of vagal atrial fibrillation / P. Schauerte [et al.] // Circulation. - 2000. - Vol. 102. - P. 2774-2780.

5. Catheter Ablation of Left Atrial Ganglionated Plexi for Atrial Fibrillation / E. Pokushalov [et al.] // Asian Cardiovasc Thorac Ann. - 2008. - Vol. 16. - P. 194-201.

6. Duration of atrial fibrillation and imminence of stroke: The Framingham Study / P.A. Wolf [et al.] // Stroke. -1996. - Vol. 27. - P. 1760-1764.

7. ’Electrical exclusion’ of a critical myocardial mass by extended pulmonary vein antrum isolation for persistent atrial fibrillation treatment / S.E. Mamchur [et al.] // Interv Med Appl Sci. - 2014. - Vol. 6(1). - P. 31-39.

8. Evaluation of catheter ablation of periatrial ganglionic plexi in patients with atrial fibrillation / S. Danik [et al.] // Am J Cardiol. - 2008. - Vol. 102(5). - P. 578-583.

9. Excessive Vagal Response During Left Atrial Ablation in a Patient with Paroxysmal Atrial Fibrillation / M. Efremidis [et al.] // Hellenic J Cardiol. - 2009. - Vol. 50. - P. 227-229.

10. Ganglionated plexi ablation for longstanding persistent atrial fibrillation/ E. Pokushalov [et al.] // Europace. -2010. - Vol. 12(3). - P. 342-346.

11. HRS/EHRA/ECAS Expert Consensus Statement on Catheter and Surgical Ablation of Atrial Fibrillation: Recommendations for Patient Selection, Procedural Techniques, Patient Management and Follow-up, Definitions, Endpoints, and Research Trial Design / H. Calkins [et al.] // Europace. - 2012. - Vol. 14. - P. 528-606.

12. Impact of atrial fibrillation on the risk of death: the Framingham Heart study / E.J. Benjamin [et al.] // Circulation. - 1998. - Vol. 98. - P. 946-952.

13. Outcome of anatomic ganglionated plexi ablation to treat paroxysmal atrial fibrillation: a 3-year follow-up study / E. Mikhaylov [et al.] // Europace. - 2011. - Vol. 13. -P. 362-370.

14. Prevalence of diagnosed atrial fibrillation in adults: national implications for rhythm management and stroke prevention: the An Ticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study / A.S. Go [et al.] // JAMA. -2001. - Vol. 285. - P. 2370-2375.

15. Prevalence, age distribution, and gender of patients with atrial fibrillation: analysis and implications / W.M. Feinberg [et al.] // Arch Intern Med. - 1995. - Vol. 155. - P. 469-743.

16. Siegel M.O. Atrial-esophageal fistula after atrial radiofrequency catheter ablation / M.O. Siegel, D.M. Parenti, G.L. Simon // Clin Infect Dis. - 2010. - Vol. 51(1). - P. 73-76.

17. Substrate and Trigger Ablation for Reduction of Atrial Fibrillation Trial-Part II (STAR AF II): design and rationale / A. Verma [et al.] // Am Heart J. - 2012. - Vol. 164. - P. 1.e6-6.e6.

18. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart Rate Variability. Standarts of Measurements, Physiological Interpretation, and Clinical Use // Circulation. - 1996. - Vol. 93. - P. 1043-1065.

19. Temporal relations of atrial fibrillation and congestive heart failure and their joint influence on mortality: the Framingham Heart Study / T.J. Wang [et al.] // Circulation. -2003. - Vol.107. - P. 2920-2925.

20. Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses / H. Calkins [et al.] // Circ Arrhythm Electrophysiol. - 2009. - Vol. 2. - P. 349-361.

21. Vagal Reactions during Cryoballoon-Based Pulmonary Vein Isolation: A Clue for Autonomic Nervous System Modulation? / M. Peyrol [et al.] // Biomed Res Int. -2016. - Vol. 2016. - Article ID 7286074.

22. Vagal responses induced by endocardial left atrial autonomic ganglion stimulation before and after pulmonary vein antrum isolation for atrial fibrillation / A. Verma [et al.] // Heart Rhythm. - 2007. - Vol. 4(9). - P. 1177-1182.

23. Новый подход в лечении фибрилляции предсердий: катетерная аблация ганглионарных сплетений в левом предсердии / Е. Покушалов [и др.] // Вестник аритмологии. - 2006. - № 45. - С. 17-27.

24. Отдаленные результаты расширенной антральной изоляции легочных вен для лечения персистирующей фибрилляции предсердий / С.Е. Мамчур [и др.] // Вестник аритмологии. - 2016. - №85. - С. 19-25.

25. Способ лечения мерцательной аритмии. Пат. 2354419 Рос. Федерация № 2006128027/14; заявл. 01.08.2006; опубл. 10.02.208, Бюл. № 13. - 7 с.

26. Явелов И.С. Вариабельность ритма сердца при острых коронарных синдромах: значение для оценки прогноза заболевания (часть 1) / И.С. Явелов, Н.А. Грацианский, Ю.А. Зуйков // Кардиология. - 1997. - №2. -С. 61-69.